GT
Galvanize Therapeutics
United States · Healthtech
Pulsed electric field medical devices for surgical soft-tissue ablation.
Product
Galvanize Therapeutics develops medical devices that deliver pulsed electric field energy to targeted tissue. Its Aliya platform combines a generator with compatible delivery devices for surgical soft-tissue ablation.
The Redwood City company commercialises Aliya in the United States while developing additional applications of its technology. Its pipeline includes RheOx, an investigational system being studied for chronic bronchitis.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series D | $130M | HealthQuest Capital — LeadAlly Bridge Group — ParticipantBraidwell LP — ParticipantElevage Medical Technologies — ParticipantFidelity Management & Research Company — ParticipantJanus Henderson Investors — ParticipantLongaeva Partners — ParticipantNorwest Venture Partners — ParticipantOlympus Innovation Ventures — ParticipantPerceptive Advisors — ParticipantSofinnova Partners — ParticipantT. Rowe Price Associates Inc. — Participant |